Safety study of LYNC-101 in healthy adults
Part of Digestive system clinical trials.
This trial tests a new medicine called LYNC-101 in healthy volunteers to see if it is safe and how the body processes it. If you are a generally healthy adult between 18 and 60, you may be able to help researchers learn about this potential treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You are in good general health with no major medical conditions.
- You weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female, and your body mass index (BMI) is between 18 and 32.
- You are willing to use effective birth control and avoid donating sperm or eggs for 3 months after the last dose.
- You have not taken any prescription or over-the-counter medications (except birth control or acetaminophen) within 2 weeks before the study starts.
- You have not participated in any other clinical trial or received any biologic drug within the past 30 days to 6 months, depending on the drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study testing a new drug called TL-003 to see if it's safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with ulcerative colitis (an inflammatory bowel disease) to understand if it might help reduce inflammation.
This study tests a new investigational drug (called LMT503) for the first time in humans, in healthy volunteers. It is a phase 1 trial that will look at how the body processes the drug and its safety, including how it behaves in the blood. The trial involves taking the drug once (single dose) or multiple times over several days, with close monitoring by the research team.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests an investigational drug called LIV001 for people with mild-to-moderate ulcerative colitis. It aims to see if the drug is safe and may help reduce inflammation in the colon.
This is an early-stage study testing a new experimental medicine called LY4302814 in healthy volunteers to see if it is safe and how the body processes it. By enrolling healthy people first, researchers can understand the drug's basic safety profile before testing it in patients with medical conditions.
This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.
Hear when a new UC - Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.